Pliant Therapeutics Growth Metrics (2020-2026) | PLRX

Growth Metrics Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Growth Ratios
EBITDA Margin Growth (1y) (Quarter)
-0.08M-0.13M-0.08M-0.13M0.07M-0.05M-0.05M-0.05M-1.64M
EBITDA Margin Growth (3y) (Quarter)
-0.28M-1.65M
EBITDA Margin (QoQ) (Quarter)
-0.02M-0.04M0.04M-0.11M0.17M-0.15M0.04M-0.10M-1.42M
EBIT Margin Growth (1y) (Quarter)
-0.08M-0.13M-0.08M-0.12M0.07M-0.05M-0.07M-0.09M-1.85M
EBIT Margin Growth (3y) (Quarter)
-0.32M-1.86M
EBIT Margin (QoQ) (Quarter)
-0.02M-0.04M0.05M-0.10M0.17M-0.16M0.03M-0.13M-1.59M
EBT Margin Growth (1y) (Quarter)
-0.08M-0.13M-0.08M-0.12M0.07M-0.04M-0.06M-0.06M-1.60M
EBT Margin Growth (3y) (Quarter)
-0.29M-1.61M
EBT Margin (QoQ) (Quarter)
-0.02M-0.04M0.05M-0.10M0.17M-0.15M0.03M-0.10M-1.38M
Enterprise Value Growth (1y) (Quarter)
21.92%24.81%27.55%32.50%32.95%-62.97%-65.10%-223.82%-239.35%-45.35%-49.23%16.44%21.35%22.75%28.03%36.64%39.79%40.23%46.32%44.09%
Enterprise Value Growth (3y) (Quarter)
-47.71%-21.12%-21.21%-21.30%-22.24%-21.41%-22.32%-21.04%-19.68%-17.13%12.44%16.77%33.35%
Enterprise Value Growth (5y) (Quarter)
-28.19%3.40%3.83%7.16%8.34%
Enterprise Value (QoQ) (Quarter)
7.62%9.40%9.25%11.12%8.24%-120.20%8.07%-74.32%3.84%5.68%5.61%2.40%9.49%7.35%12.06%14.08%13.99%8.02%21.03%10.50%
FCF Margin Growth (1y) (Quarter)
-0.13M-0.11M-0.06M-0.11M0.06M0.01M-0.06M-0.06M-0.98M
FCF Margin Growth (3y) (Quarter)
-0.22M-1.04M
FCF Margin (QoQ) (Quarter)
-0.04M-0.04M0.05M-0.08M0.12M-0.09M-0.02M-0.08M-0.79M
Interest Coverage Ratio Growth (1y) (Quarter)
13.41%-41.73%-24.20%13.02%52.91%52.99%56.37%37.35%19.33%50.95%-171.16%
Interest Coverage Ratio Growth (3y) (Quarter)
30.97%31.12%-13.69%
Interest Coverage Ratio (QoQ) (Quarter)
38.06%-11.16%-14.72%-9.61%-1.39%2.59%19.65%40.66%-1.22%9.59%-15.37%23.60%38.45%-399.80%
Net Margin Growth (1y) (Quarter)
-0.08M-0.13M-0.08M-0.12M0.07M-0.04M-0.06M-0.06M-1.60M
Net Margin Growth (3y) (Quarter)
-1.61M
Net Margin (QoQ) (Quarter)
-0.02M-0.04M0.05M-0.10M0.17M-0.15M0.03M-0.10M-1.38M
Operating Margin Growth (1y) (Quarter)
-0.08M-0.13M-0.08M-0.12M0.07M-0.05M-0.07M-0.09M-1.85M
Operating Margin Growth (3y) (Quarter)
-0.32M-1.86M
Operating Margin (QoQ) (Quarter)
-0.02M-0.04M0.05M-0.10M0.17M-0.16M0.03M-0.13M-1.59M
Return on Assets Growth (1y) (Quarter)
0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M
Return on Assets Growth (3y) (Quarter)
0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M
Return on Assets Growth (5y) (Quarter)
-1.000.00M0.00M
Return on Assets (QoQ) (Quarter)
0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M
Return on Capital Employed Growth (1y) (Quarter)
-0.00M-0.00M-0.00M-0.00M-527.00885.000.00M0.00M0.00M42.00-869.00-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-783.00999.00
Return on Capital Employed Growth (3y) (Quarter)
-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-776.00-0.00M-0.00M-0.00M
Return on Capital Employed Growth (5y) (Quarter)
-0.01M-0.01M-0.00M
Return on Capital Employed (QoQ) (Quarter)
-455.00-762.00-663.00-763.00-0.00M0.00M749.00614.00276.00-440.00-408.00-298.00-407.00-825.00-656.00-971.00-432.00409.00211.00811.00
Return on Equity Growth (1y) (Quarter)
-1.000.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M
Return on Equity Growth (3y) (Quarter)
0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M
Return on Equity Growth (5y) (Quarter)
0.00M-1.00-1.00-1.000.00M
Return on Equity (QoQ) (Quarter)
0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M
Return on Sales Growth (1y) (Quarter)
-8.00-13.00-8.00-12.007.00-4.00-6.00-6.00-160.00-23.00-84.00-660.00
Return on Sales Growth (3y) (Quarter)
-29.00-161.00-40.00-98.00-678.00
Return on Sales (QoQ) (Quarter)
-2.00-4.005.00-10.0017.00-15.003.00-10.00-138.00122.00-58.00-586.00